Vaxitet Vaccine 5 ml Banglades - angol - DGDA (Directorate General of Drug Administration)

vaxitet vaccine 5 ml

incepta pharmaceuticals ltd., vaccine division - adsorbed tetanus vaccine - vaccine - 40 %/.5 ml

TYPHIM VI- salmonella typhi ty2 vi polysaccharide antigen injection, solution Egyesült Államok - angol - NLM (National Library of Medicine)

typhim vi- salmonella typhi ty2 vi polysaccharide antigen injection, solution

a-s medication solutions - salmonella typhi ty2 vi polysaccharide antigen (unii: 7194h8w3kt) (salmonella typhi ty2 vi polysaccharide antigen - unii:7194h8w3kt) - salmonella typhi ty2 vi polysaccharide antigen 25 ug in 0.5 ml - typhim vi vaccine is indicated for active immunization for the prevention of typhoid fever caused by s typhi and is approved for use in persons two years of age or older. immunization with typhim vi vaccine should occur at least two weeks prior to expected exposure to s typhi . typhim vi vaccine is not indicated for routine immunization of individuals in the united states (us). (14) selective immunization against typhoid fever is recommended under the following circumstances: 1) travelers to areas where a recognized risk of exposure to typhoid exists, particularly ones who will have prolonged exposure to potentially contaminated food and water, 2) persons with intimate exposure (ie, continued household contact) to a documented typhoid carrier, and 3) workers in microbiology laboratories who frequently work with s typhi . (14) typhoid vaccination is not required for international travel, but is recommended for travelers to such areas as africa, asia, and central and south america where there is a recognized r

TYPHIM VI- salmonella typhi ty2 vi polysaccharide antigen injection, solution Egyesült Államok - angol - NLM (National Library of Medicine)

typhim vi- salmonella typhi ty2 vi polysaccharide antigen injection, solution

a-s medication solutions - salmonella typhi ty2 vi polysaccharide antigen (unii: 7194h8w3kt) (salmonella typhi ty2 vi polysaccharide antigen - unii:7194h8w3kt) - salmonella typhi ty2 vi polysaccharide antigen 25 ug in 0.5 ml - typhim vi vaccine is indicated for active immunization for the prevention of typhoid fever caused by s typhi and is approved for use in persons two years of age or older. immunization with typhim vi vaccine should occur at least two weeks prior to expected exposure to s typhi . typhim vi vaccine is not indicated for routine immunization of individuals in the united states (us). (14) selective immunization against typhoid fever is recommended under the following circumstances: 1) travelers to areas where a recognized risk of exposure to typhoid exists, particularly ones who will have prolonged exposure to potentially contaminated food and water, 2) persons with intimate exposure (ie, continued household contact) to a documented typhoid carrier, and 3) workers in microbiology laboratories who frequently work with s typhi . (14) typhoid vaccination is not required for international travel, but is recommended for travelers to such areas as africa, asia, and central and south america where there is a recognized r

Vaxitet Vaccine Banglades - angol - DGDA (Directorate General of Drug Administration)

vaxitet vaccine

incepta pharmaceuticals ltd., vaccine division - adsorbed tetanus vaccine - vaccine - 5 lf/.5 ml

Hepa-B Vaccine for Adult Banglades - angol - DGDA (Directorate General of Drug Administration)

hepa-b vaccine for adult

incepta pharmaceuticals ltd., vaccine division - hepatitis b vaccine - vaccine - 20 mcg/ml

Hepa-B Vaccine for Pediatric Banglades - angol - DGDA (Directorate General of Drug Administration)

hepa-b vaccine for pediatric

incepta pharmaceuticals ltd., vaccine division - hepatitis b vaccine - vaccine - 10 mcg/ml

Measles Vaccine Banglades - angol - DGDA (Directorate General of Drug Administration)

measles vaccine

incepta pharmaceuticals ltd., vaccine division - measles vaccine (live) - vaccine - .5 ml

Vaxphoid Vaccine Banglades - angol - DGDA (Directorate General of Drug Administration)

vaxphoid vaccine

incepta pharmaceuticals ltd., vaccine division - typhoid polysaccharide vaccine - vaccine - 25 mcg/.5 ml

AviPro Salmonella Vac E Formulation:   Each dose contains:   Salmonella Enteritidis (Strain Sm24/Rif12/Ssq)...................................   >10^8 CFU CFU-Colony Forming Unit Freeze Dried Powder for   Oral Suspension Fülöp-szigetek - angol - FDA (Food And Drug Administration)

avipro salmonella vac e formulation: each dose contains: salmonella enteritidis (strain sm24/rif12/ssq)................................... >10^8 cfu cfu-colony forming unit freeze dried powder for oral suspension

elanco philippines, inc.; distributor: elanco philippines, inc. - live attenuated salmonella enteritidis vaccine (vet.) - freeze dried powder for oral suspension - formulation: each dose contains: salmonella enteritidis (strain sm24/rif12/ssq)................................... >10^8 cfu cfu-colony forming unit

Avipro Salmonella Duo Each dose contains:   Salmonella Enteritidis (Sm24/Rif12/Ssq Strain) ....   2108 CFU Salmonella Typhimurium (Nal2/Rif9/Rtt Strain) ...   2108 CFU OD-Optical Density Freeze Dried Powder for   Oral Suspension Fülöp-szigetek - angol - FDA (Food And Drug Administration)

avipro salmonella duo each dose contains: salmonella enteritidis (sm24/rif12/ssq strain) .... 2108 cfu salmonella typhimurium (nal2/rif9/rtt strain) ... 2108 cfu od-optical density freeze dried powder for oral suspension

elanco philippines, inc.; distributor: elanco philippines, inc. - live attenuated salmonella enteritidis , salmonella typhimurium vaccine (vet.) - freeze dried powder for oral suspension - each dose contains: salmonella enteritidis (sm24/rif12/ssq strain) .... 2108 cfu salmonella typhimurium (nal2/rif9/rtt strain) ... 2108 cfu od-optical density